Samsung Medison, a world medical gear firm and an affiliate of Samsung Electronics, at this time introduced it has signed an settlement to amass 100% of the shares of Sonio SAS, a fetal ultrasound AI software program firm.
Established in 2020 to boost girls and kids’s well being globally by means of medical developments, Sonio has developed IT options and AI assistant options for obstetrics and gynecology ultrasound that help medical professionals within the analysis and documentation of ultrasound exams.
Sonio Detect, an FDA 510(ok) cleared AI assistant, leverages deep studying networks to make sure increased picture high quality in actual time and enhance high quality of care by means of higher scientific accuracy.
Following the completion of the transaction, Sonio will stay an impartial firm headquartered in France and can proceed its industrial progress independently whereas its services and products will stay suitable with all ultrasound machine makers.
Together with Sonio’s world-class AI experience, Samsung Medison’s modern ultrasound techniques will assist deliver to market breakthrough AI-enhanced workflows and speed up innovation in affected person outcomes and high quality of prenatal care.
“We have great respect and admiration for what the Sonio team has built in the area of maternal care. Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” stated Yong Kwan Kim, Samsung Medison CEO. “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”
“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides,” stated Cécile Brosset, Sonio CEO. “We have found in Samsung Medison an amazing, trusting partner to pursue and accelerate our roadmap and mission. In addition to close collaboration with Samsung Medison, as an independent company, Sonio will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare.”
The closing of the transaction is topic to relevant regulatory approvals, and notably the approval of the French Ministry of the Economy and Finance.
About Samsung Medison
Samsung Medison is a number one world medical machine firm, specializing in diagnostic imaging gadgets. With a mission to deliver well being and well-being to individuals’s lives, the corporate is dedicated to creating a brand new future for medical professionals and sufferers all over the world throughout numerous medical fields. In 2011, Samsung Medison turned an affiliate firm of Samsung Electronics, integrating the world’s finest IT, picture processing, semiconductor and communication applied sciences into medical gadgets. For extra data, please go to https://www.samsungmedison.com/
About Sonio
Sonio’s AI-enhanced software program empowers prenatal sonographers and ultrasound readers and assists them in performing prenatal examinations that meet the best high quality requirements, whereas guaranteeing the completeness of every examination, streamlining their workflow and rising the accuracy of prenatal diagnoses. Sonio’s software program is the product of greater than 5 years of analysis and collaboration between main consultants within the areas of maternal-fetal drugs and AI. Sonio’s buyers embrace Elaia Partners, Bpifrance’s French Tech Seed fund, OneRagtime, Cross Border Impact Ventures and EIC Fund (European Innovation Council). To be taught extra about Sonio, go to our web site https://sonio.ai/
